Maintenance treatments for acute myeloid leukemia

Last medical review:

Maintenance is a third phase of treatment that may be used for people with AML that has intermediate or unfavourable chromosome changes. Maintenance follows consolidation. The goal of maintenance treatment for AML is to prevent leukemia cells from coming back (called relapse) and clear any leukemia cells that might remain (called measurable residual disease). Maintenance therapy may be given for a long time until the disease progresses or it becomes too hard to cope with the side effects.

Chemotherapy

Chemotherapy uses anticancer drugs to destroy cancer cells. Chemotherapy is the main maintenance treatment for AML. Maintenance chemotherapy may be given to people with AML with intermediate or unfavourable chromosome changes who are unable to have a stem cell transplant. Maintenance chemotherapy is most commonly given as oral azacitidine (Onureg).

Find out more about chemotherapy for AML.

Targeted therapy

Targeted therapy uses drugs to target specific molecules (such as proteins) on cancer cells or inside them to stop the growth and spread of cancer.

Sorafenib (Nexavar) is an FLT3 inhibitor that may be used as maintenance therapy for people who have received a stem cell transplant and are in remission from AML with the FLT3 mutation.

Find out more about targeted therapy for AML.

Supportive therapy

Supportive therapy is important during every phase of AML treatment. It is used to treat the complications that usually happen with treatments for AML and the disease itself.

Supportive therapies given during maintenance treatment may include:

  • antibiotics and antifungals to treat infections
  • growth factors to help the bone marrow recover from chemotherapy (chemotherapy can affect the bone marrow so it doesn’t make enough healthy blood cells, which can increase the risk for infection)
  • transfusions of red blood cells, platelets, fresh frozen plasma and cryoprecipitate (a product that replaces clotting factors) as needed

Find out more about supportive therapy.

Clinical trials

Talk to your doctor about clinical trials open to people with AML in Canada. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society